Jeff Yass’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
Other funds holding ONCY
IAIM
Jeff Yass's ONCY Position: Q3 2026 in Review
Jeff Yass sold out of Oncolytics Biotech (ONCY) in Q3 2026, closing a stake of 134,129 shares — an estimated $127K sold.
Jeff Yass first reported a position in ONCY in Q4 2018 and held it in 8 quarters. The position peaked at $127K in Q2 2026. 77 funds tracked by Wall St. Rank hold ONCY as of Q3 2026.
- Jeff Yass reported no remaining Oncolytics Biotech position as of Q3 2026 after selling out during the quarter.
- Jeff Yass sold 134,129 Oncolytics Biotech shares in Q3 2026, an estimated $127K.
- Jeff Yass first reported a position in Oncolytics Biotech in Q4 2018 and held it in 8 quarters.
- Jeff Yass's Oncolytics Biotech position peaked at $127K in Q2 2026.
- 77 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.